Literature DB >> 23771016

Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals.

Asako Miyaki1, Seiji Maeda, Youngju Choi, Nobuhiko Akazawa, Miki Eto, Kiyoji Tanaka, Ryuichi Ajisaka.   

Abstract

BACKGROUND: Obesity and increased arterial stiffness are independent risk factors for cardiovascular disease. The degree of arterial stiffness in obese individuals is greater than that in normal-weight subjects. Pentraxin 3 (PTX3) is mainly produced by vascular tissues and exerts a cardioprotective effect. However, the relationship between PTX3 and arterial stiffness in obese individuals has not yet been clarified. In this study, we examined the relationships between obesity, arterial stiffness, and PTX3 levels in 282 subjects.
METHODS: All participants were classified as normal weight, overweight, or obese on the basis of their body mass index. We measured the brachial-ankle pulse wave velocity (baPWV; an index of arterial stiffness) and plasma PTX3 concentrations in all subjects. Additionally, the carotid-femoral PWV (cfPWV) was measured in 173 subjects.
RESULTS: We found that baPWV and cfPWV in overweight and obese subjects were significantly higher than those in normal-weight subjects. Plasma PTX3 concentrations in normal-weight subjects were significantly higher than those in overweight and obese subjects. Moreover, PTX3 had a significant negative correlation with baPWV. However, stepwise multivariable linear regression analysis did not indicate any associations between these parameters.
CONCLUSIONS: Arterial stiffness is increased in overweight and obese individuals. The increase in arterial stiffness may, at least in part, be associated with an obesity-related reduction in plasma PTX3 concentrations.

Entities:  

Keywords:  arterial stiffness; blood pressure; cardiovascular disease cardiovascular protection; hypertension; obesity; pentraxin 3.

Mesh:

Substances:

Year:  2013        PMID: 23771016     DOI: 10.1093/ajh/hpt103

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  13 in total

1.  Effects of habitual aerobic exercise on the relationship between intramyocellular or extramyocellular lipid content and arterial stiffness.

Authors:  N Hasegawa; S Fujie; T Kurihara; T Homma; K Sanada; K Sato; T Hamaoka; M Iemitsu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

2.  Serum pentraxin-3 levels and flow-mediated dilation in dipper and non-dipper hypertension.

Authors:  Çağlar Alp; Mehmet Tolga Dogru; Muhammed Karadeniz; Taner Sarak; Vahit Demir; Yunus Çelik; Hüseyin Kandemir; Üçler Kısa
Journal:  J Clin Lab Anal       Date:  2018-11-09       Impact factor: 2.352

3.  Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.

Authors:  E C Verna; J Patel; R Bettencourt; P Nguyen; C Hernandez; M A Valasek; T Kisselva; D A Brenner; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-06-29       Impact factor: 8.171

4.  Impact of acute high-intensity interval exercise on plasma pentraxin 3 and endothelial function in obese individuals-a pilot study.

Authors:  Aaron L Slusher; Brandon G Fico; Katelyn M Dodge; Ryan S Garten; Peter J Ferrandi; Alexandra A Rodriguez; Gabriel Pena; Chun-Jung Huang
Journal:  Eur J Appl Physiol       Date:  2021-02-27       Impact factor: 3.078

5.  Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?

Authors:  Figen Kir Sahin; Serap Baydur Sahin; Gulsah Balik; Ulku Mete Ural; Yesim Bayoglu Tekin; Medine Cumhur Cure; Senol Senturk; Suleyman Yuce; Erkan Cure
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 6.  The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation.

Authors:  Aaron L Slusher; Chun-Jung Huang; Edmund O Acevedo
Journal:  Mediators Inflamm       Date:  2017-03-17       Impact factor: 4.711

7.  Cardiorespiratory Fitness Suppresses Age-Related Arterial Stiffening in Healthy Adults: A 2-Year Longitudinal Observational Study.

Authors:  Yuko Gando; Haruka Murakami; Ryoko Kawakami; Kenta Yamamoto; Hiroshi Kawano; Noriko Tanaka; Susumu S Sawada; Nobuyuki Miyatake; Motohiko Miyachi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-10       Impact factor: 3.738

8.  Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome.

Authors:  Rocco Barazzoni; Aneta Aleksova; Cosimo Carriere; Maria Rosa Cattin; Michela Zanetti; Pierandrea Vinci; Davide Stolfo; Gianfranco Guarnieri; Gianfranco Sinagra
Journal:  Cardiovasc Diabetol       Date:  2013-11-11       Impact factor: 9.951

9.  Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study.

Authors:  Tove Lekva; Annika Elisabeth Michelsen; Jens Bollerslev; Errol R Norwitz; Pål Aukrust; Tore Henriksen; Thor Ueland
Journal:  Cardiovasc Diabetol       Date:  2016-02-03       Impact factor: 9.951

10.  Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Kadir Ozturk; Omer Kurt; Tolga Dogan; Alptug Ozen; Hakan Demirci; Fatih Yesildal; Murat Kantarcioglu; Turker Turker; Ahmet Kerem Guler; Yıldırım Karslioglu; Battal Altun; Ahmet Uygun; Sait Bagci
Journal:  Gastroenterol Res Pract       Date:  2016-02-22       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.